Wisconsin joins lawsuit challenging Amgen’s plan to acquire drug company
Wisconsin and five other states last week joined the Federal Trade Commission’s lawsuit to stop Amgen, one of the world’s largest pharmaceutical companies, from buying another drug company in a $28 billion deal.
To access this content, you must purchase a Premium membership, or log in if you are a member.
